64 results
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding … or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
), (ii) or (iii), a “Material Adverse Effect”) and no “Proceeding” (which for purposes of this Agreement shall mean any action, claim, suit, investigation … or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding … or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective
8-K
EX-4.2
dzousuezfq9i5zsor6r
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
8-K
EX-10.1
sy7gbgng835oao
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
8-K
EX-4.1
77wj1 x8dt0
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
8-K
EX-10.2
0enb2su4p6x r8hv1yqz
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm